Digestive health: The silent cost burden for payers
Gastrointestinal issues now rank among the top five chronic conditions driving medical and pharmacy costs. Consequently, these conditions — including irritable bowel syndrome, ulcerative colitis and Crohn's disease — contribute to an enormous cost for health plans and their members.
This whitepaper closely examines digestive diseases' financial and clinical impact, including high claim volumes and delayed diagnoses, and why it's critical for payers to develop targeted interventions to manage these challenges now.
Key learnings:
This whitepaper closely examines digestive diseases' financial and clinical impact, including high claim volumes and delayed diagnoses, and why it's critical for payers to develop targeted interventions to manage these challenges now.
Key learnings:
- The broader implications of poor gut health, including mental health and immune function
- Actionable strategies to reduce costs and improve outcomes with early detection, enhanced access to care and integrated care models
- Interventions saving some payers up to $2,000 per member annually
Please fill out the form to download the whitepaper.